COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
77.12 EUR
+0.08 (+0.1%)
Taking everything into account, CBHD scores 6 out of 10 in our fundamental rating. CBHD was compared to 68 industry peers in the Health Care Equipment & Supplies industry. CBHD scores excellent on profitability, but there are some minor concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate. CBHD also has an excellent dividend rating. With these ratings, CBHD could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
- In the past year CBHD was profitable.
- In the past year CBHD had a positive cash flow from operations.
- Each year in the past 5 years CBHD has been profitable.
- In the past 5 years CBHD always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of CBHD (7.52%) is better than 82.35% of its industry peers.
- CBHD has a better Return On Equity (22.55%) than 91.18% of its industry peers.
- The Return On Invested Capital of CBHD (12.65%) is better than 92.65% of its industry peers.
- CBHD had an Average Return On Invested Capital over the past 3 years of 13.59%. This is above the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
- The Profit Margin of CBHD (13.04%) is better than 76.47% of its industry peers.
- CBHD's Profit Margin has declined in the last couple of years.
- CBHD's Operating Margin of 27.52% is amongst the best of the industry. CBHD outperforms 94.12% of its industry peers.
- In the last couple of years the Operating Margin of CBHD has declined.
- With a decent Gross Margin value of 67.97%, CBHD is doing good in the industry, outperforming 76.47% of the companies in the same industry.
- CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CBHD is creating value.
- The number of shares outstanding for CBHD remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, CBHD has more shares outstanding
- CBHD has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.95 indicates that CBHD is not in any danger for bankruptcy at the moment.
- CBHD has a better Altman-Z score (3.95) than 70.59% of its industry peers.
- The Debt to FCF ratio of CBHD is 4.34, which is a neutral value as it means it would take CBHD, 4.34 years of fcf income to pay off all of its debts.
- CBHD has a Debt to FCF ratio (4.34) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.24 is on the high side and indicates that CBHD has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.24, CBHD is doing worse than 80.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.95 |
ROIC/WACC2.28
WACC5.55%
2.3 Liquidity
- CBHD has a Current Ratio of 1.61. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
- CBHD has a Current ratio (1.61) which is in line with its industry peers.
- CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.00, CBHD perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.93%.
- Measured over the past years, CBHD shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.02% on average per year.
- CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
- CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.49% yearly.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
- Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.23% on average per year.
- Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 6.95% on average per year.
EPS Next Y46.79%
EPS Next 2Y27.16%
EPS Next 3Y21.25%
EPS Next 5Y16.23%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 32.40, CBHD can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of CBHD is on the same level as its industry peers.
- When comparing the Price/Earnings ratio of CBHD to the average of the S&P500 Index (27.54), we can say CBHD is valued inline with the index average.
- A Price/Forward Earnings ratio of 22.10 indicates a rather expensive valuation of CBHD.
- CBHD's Price/Forward Earnings is on the same level as the industry average.
- CBHD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.4 | ||
| Fwd PE | 22.1 |
4.2 Price Multiples
- CBHD's Enterprise Value to EBITDA is on the same level as the industry average.
- Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.21 | ||
| EV/EBITDA | 15.61 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- CBHD has a very decent profitability rating, which may justify a higher PE ratio.
- CBHD's earnings are expected to grow with 21.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y27.16%
EPS Next 3Y21.25%
5. Dividend
5.1 Amount
- CBHD has a Yearly Dividend Yield of 4.08%, which is a nice return.
- CBHD's Dividend Yield is rather good when compared to the industry average which is at 1.13. CBHD pays more dividend than 97.06% of the companies in the same industry.
- CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.08% |
5.2 History
- The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- CBHD pays out 136.36% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP136.36%
EPS Next 2Y27.16%
EPS Next 3Y21.25%
FRA:CBHD (1/15/2026, 7:00:00 PM)
77.12
+0.08 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-06 2026-02-06
Inst Owners28.86%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.21B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70.4
Price Target91.92 (19.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.08% |
Yearly Dividend2.94
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.74%
PT rev (3m)-2.74%
EPS NQ rev (1m)-4.12%
EPS NQ rev (3m)12.82%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.3%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)9%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.4 | ||
| Fwd PE | 22.1 | ||
| P/S | 4.35 | ||
| P/FCF | 23.21 | ||
| P/OCF | 18.23 | ||
| P/B | 7.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.61 |
EPS(TTM)2.38
EY3.09%
EPS(NY)3.49
Fwd EY4.52%
FCF(TTM)3.32
FCFY4.31%
OCF(TTM)4.23
OCFY5.49%
SpS17.75
BVpS10.26
TBVpS-8.72
PEG (NY)0.69
PEG (5Y)N/A
Graham Number23.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.95 |
F-Score6
WACC5.55%
ROIC/WACC2.28
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y46.79%
EPS Next 2Y27.16%
EPS Next 3Y21.25%
EPS Next 5Y16.23%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.49%
EBIT Next 3Y14.67%
EBIT Next 5Y11.91%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CBHD.DE.
Can you provide the valuation status for COLOPLAST-B?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
How financially healthy is COLOPLAST-B?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.79% in the next year.